SpaceX lowers its IPO valuation goal to $1.8 trillion, suggesting a more cautious approach to the public markets that could weigh on…
The 'Sell in May' adage collapsed in 2026 as US stocks rallied, with the S&P 500 and Nasdaq posting gains that forced…
Billion-dollar molecular glue deals reshape the cancer drug landscape, driving biotech valuations and pharma licensing activity to new highs.
A Swedish trade union has reduced the scope of its long-running strike against Tesla, likely boosting the EV maker's European operations and…
The arrest order for a Philippine senator over graft sparked a selloff in the peso and local equities, deepening political uncertainty.
Big Caring, Malaysia’s top pharma retailer, targets a $750 million IPO, marking a major test for equity capital markets in the region.
Chinese fast-food chain Zhengxin Food is reportedly exploring a Hong Kong IPO, signaling renewed activity in the city's equity capital markets.
SpaceX reduces its IPO valuation target to over $1.8 trillion, recalibrating market expectations for the private space giant’s potential public debut.
Samsung claims lead in AI memory chip race by shipping HBM3E samples, challenging SK Hynix and Micron for Nvidia's business, with potential…
Dell stock soars 40% as AI server sales forecast surges to $60 billion, topping Wall Street expectations and signaling enduring momentum in…
Futu Holdings said 20% of its revenue came from mainland China clients, revealing a significant dependence on the mainland despite China's strict…
Insurance Australia Group settles Greensill litigation, clearing a key legal risk and potentially boosting investor confidence in the insurer's stability.